Ig Vena

Human Normal Immunoglobulin, the active ingredient in Ig Vena, is an immunoglobulin presented as a solution for injection for intravenous use. It treats primary and secondary immunodeficiency disorders and immune thrombocytopenic purpura in patients with compromised immune function.

GNH USA supplies Ig Vena as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Ig Vena, a pooled human immunoglobulin, is used to replace deficient antibodies in various immune‑mediated conditions.

- Primary immunodeficiency disorders: restores IgG levels to reduce infection frequency. - Secondary immunodeficiency: provides passive immunity in patients with acquired antibody loss. - Immune thrombocytopenic purpura: modulates immune response to increase platelet counts.

Ig Vena may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Headache: mild to moderate headache occurring during or after infusion. - Fever or chills: transient rise in temperature or shivering. - Nausea: mild gastrointestinal upset. - Fatigue: temporary feeling of tiredness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical intervention. - Acute renal failure: sudden loss of kidney function, especially in patients with pre‑existing renal disease. - Thromboembolic events: formation of blood clots that may lead to vascular occlusion. - Hemolysis: destruction of red blood cells causing anemia.

Before using Ig Vena, several safety considerations should be observed. - Pre‑infusion assessment: evaluate patient’s medical history, especially renal, cardiac, and hepatic status. - Monitoring during infusion: observe vital signs and watch for signs of hypersensitivity. - Rate of administration: infuse slowly at first and adjust based on tolerance. - Concomitant immunosuppressants: assess risk of infection when used with other immune‑modulating agents. - Pregnancy and lactation: use only if potential benefit justifies potential risk; data are limited. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Ig Vena can interact with other medicines, affecting safety or efficacy.

Major Interactions (Avoid): - Live vaccines: may reduce vaccine efficacy or increase risk of infection; avoid concurrent administration. - High‑dose aspirin or NSAIDs: increase risk of bleeding when combined with Ig therapy.

Moderate Interactions (Monitor Closely): - ACE inhibitors: may potentiate risk of renal impairment. - Diuretics: monitor fluid balance and renal function. - Immunosuppressive agents (e.g., rituximab): may alter immune response; adjust monitoring.